Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition

• Published in: Cell death & disease Vol. 9; no. 9; pp. 854 - 17
• Main Authors: Li, Qiang, Li, Bowen, Li, Qing, Wei, Song, He, Zhongyuan, Huang, Xiaoxu, Wang, Lu, Xia, Yiwen, Xu, Zhipeng, Li, Zheng, Wang, Weizhi, Yang, Li, Zhang, Diancai, Xu, Zekuan
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 28.08.2018; Springer Nature B.V
• Subjects: 13/1; 13/109; 13/44; 13/89; 14/1; 14/28; 14/34; 14/5; 38/1; 38/35; 45/90; 59/5; 64/60; 82/1; 82/80; Animals; Antibodies; Biochemistry; Cell Biology; Cell Culture; Cell Line, Tumor; Cell Movement - genetics; Cell Proliferation - genetics; Chromosome 5; Epithelial-Mesenchymal Transition - genetics; Epithelium - pathology; Exosomes; Exosomes - genetics; Exosomes - pathology; Female; Gastric cancer; Gene Expression Regulation, Neoplastic - genetics; Humans; Immunology; Life Sciences; Male; Mesenchyme; Metastases; Metastasis; Mice; Mice, Nude; MicroRNAs - genetics; Middle Aged; Neoplasm Metastasis - genetics; Neoplasm Metastasis - pathology; Peritoneal Neoplasms - genetics; Peritoneal Neoplasms - pathology; Peritoneum; Peritoneum - pathology; Polymerase chain reaction; Signal Transduction - genetics; Smad protein; Smad7 protein; Smad7 Protein - genetics; Stomach Neoplasms - genetics; Stomach Neoplasms - pathology; Therapeutic applications; Therapeutic targets; Transforming Growth Factor beta - genetics; Transmission electron microscopy; Tumors
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/s41419-018-0928-8

Peritoneal metastasis is a primary metastatic route for gastric cancers, and the mechanisms underlying this process are still unclear. Peritoneal mesothelial cells (PMCs) undergo mesothelial-to-mesenchymal transition (MMT) to provide a favorable environment for metastatic cancer cells. In this study, we investigated how the exosomal miR-21-5p induces MMT and promotes peritoneal metastasis. Gastric cancer (GC)-derived exosomes were identified by transmission electron microscopy and western blot analysis, then the uptake of exosomes was confirmed by PKH-67 staining. The expression of miR-21-5p and SMAD7 were measured by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot, and the interactions between miR-21-5p and its target genes SMAD7 were confirmed by Luciferase reporter assays. The MMT of PMCs was determined by invasion assays, adhesion assays, immunofluorescent assay, and western blot. Meanwhile, mouse model of tumor peritoneal dissemination model was performed to investigate the role of exosomal miR-21-5p in peritoneal metastasis in vivo. We found that PMCs could internalize GC-derived exosomal miR-21-5p and led to increased levels of miR-21-5p in PMCs. Through various types of in vitro and in vivo assays, we confirmed that exosomal miR-21-5p was able to induce MMT of PMCs and promote tumor peritoneal metastasis. Moreover, our study revealed that this process was promoted by exosomal miR-21-5p through activating TGF-β/Smad pathway via targeting SMAD7. Altogether, our data suggest that exosomal miR-21-5p induces MMT of PMCs and promote cancer peritoneal dissemination by targeting SMAD7. The exosomal miR-21-5p may be a novel therapeutic target for GC peritoneal metastasis.